Novo Nordisk: A Rare Case of Pharma With Balanced Risk and Reward [Yahoo! Finance News]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance News
Denmark-based Novo Nordisk OCSE:NOVO B) NVO) is a global developer of drugs to treat chronic diseases, including diabetes, obesity and hemophilia. The company has sales in 170 countries. Diabetes and obesity together accounted for 84% of the company's fiscal 2018 sales. The U.S. is the most significant revenue contributor 49% as of 2018 sales), followed by Europe 19%), Africa, Asia, Middle East and Oceania 11%) and China 10%). Although we are typically cautious about the pipeline risk associated with investing in pharma, we appreciate the strategic focus, dominant market positions and secular growth opportunities at Novo Nordisk. The company dominates the insulin market in almost every corner of the planet, holding 40% of the market share in North America, 50% in China, 44% in Europe and 50% in Latin America. Overall, it serves roughly 30% of the global diabetes value market, which has been growing at a CAGR of 16% since 2014. Investors may also want to note the significant diebete
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Yahoo Finance [Yahoo! Finance]Yahoo! Finance
- Pound slumps to lowest level in four months [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk A/S (NVO) Trembled At The End Of The Quarter [Yahoo! Finance]Yahoo! Finance
- Dr. Sanjay Gupta: Blockbuster weight loss drugs are revealing what we still don't understand about obesity [CNN]CNN
- Dr. Sanjay Gupta: Blockbuster weight loss drugs are revealing what we still don't understand about obesity [CNN]CNN
NVO
Earnings
- 11/7/24 - Beat
NVO
Sec Filings
- 11/14/24 - Form 6-K
- 11/13/24 - Form 6-K
- 11/8/24 - Form 6-K
- NVO's page on the SEC website